Efficiency considerations of donor fatigue, universal access to ARTs and health systems

Sexually Transmitted Infections

Volumn 88, Issue 2, 2012, Pages 75-78

  Grépin, Karen A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DELIVERY OF HEALTH CARE; FINANCIAL MANAGEMENT; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS;

EID: 84857378099     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050148     Document Type: Review

References (22)

1. UNAIDS. AIDS at 30: nations at the crossroads. In: UNAIDS, ed. Geneva, Switzerland: UNAIDS, 2011.
2. Hecht R, Stover J, Bollinger L, et al. Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31. Lancet 2010;376:1254-60.
3. UNAIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. Geneva, Switzerland: UNAIDS, 2010.
4. Hardon A, Blume S. Shifts in global immunisation goals (1984-2004): unfinished agendas and mixed results. Soc Sci Med 2005;60:345-56. (Pubitemid 39452550)
5. Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002;415:680-5. (Pubitemid 34136401)
6. Soni A, Gupta R. Bridging the resource gap: improving value for money in HIV/AIDS treatment. Health Aff (Millwood) 2009;28:1617-28.
7. Moszynski P. News: donor fatigue is slashing access to AIDS care in Africa, warns charity. BMJ 2010;340:c2844.
8. Grepin K, Leach-Kemon K, Schneider M, et al. Development assistance for health: a review of the datasets. Health Policy Plann. Forthcoming.
9. Kaiser Family Foundation and UNAIDS. Financing the Response to AIDS in Lowand Middle- Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2010. Washington, DC: Kaiser Family Foundation, 2011.
10. Menzies N, Berruti A, Berzon R, et al. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS 2011;25:1753-60. (London, England) (21412127).
11. Brentlinger PE, Assan A, Mudender F, et al. Task shifting in Mozambique: crosssectional evaluation of non-physician clinicians' performance in HIV/AIDS care. Hum Resour Health 2010;8:23.
12. Grepin K, Jack W. Potential economic consequences of donor-financed HIV spending. Unpublished manuscript. 2008.
13. Fulton B, Scheffler R, Sparkes S, et al. Health workforce skill mix and task shifting in low income countries: a review of recent evidence. Hum Resour Health 2011;9:1.
14. Rabkin M, El-Sadr W. Why reinvent the wheel? Leveraging the lessons of HIV scaleup to confront non-communicable diseases. Glob Public Health 2011;6:247-56.
15. Barnighausen T, Bloom DE, Humair S. Going horizontaleshifts in funding of global health interventions. N Engl J Med 2011;364:2181-3.
16. Grepin KA. Leveraging HIV programs to deliver an integrated package of health services: some words of caution. J Acquir Immune Defic Syndr 2011;57(Suppl 2): S77-9.
17. Schwartlander B, Stover J, Hallett T, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011;6736:60702-2.
18. Daniels N, Bryant J, Castano R, et al. Benchmarks of fairness for health care reform: a policy tool for developing countries. Bull World Health Organ 2000;78:740-50. (Pubitemid 30489590)
19. Over M. Prevention Failure: The Ballooning Entitlement Burden of U.S. Global Aids Treatment Spending and What to do About It. Washington, DC: Center for Global Development, 2008.
20. Galarraga O, Colchero MA, Wamai R. HIV prevention cost-effectiveness: a systematic review. BMC Public Health 2009;9(Suppl 1):S5.
21. Severe P, Juste MA, Ambroise A, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med 2010;363:257-65.
22. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.